Related by context. Frequent words. (Click for all words.) 61 Complete Response 61 Phase III pivotal 60 Phase 2b study 60 secondary efficacy endpoints 59 PROPEL trial 59 Phase 2a trial 59 randomized Phase III 59 confirmatory Phase III 59 phase IIb 59 BLA submission 58 evaluable patients 58 Phase 2a clinical 58 phase 2a 58 dose escalation trial 57 alvimopan 57 Phase 2b trial 57 MOZOBIL 57 Phase IIa trial 57 phase IIa 57 registrational 57 ponatinib 57 Phase 1b clinical 56 multicenter clinical 56 Genasense R oblimersen 56 Phase 1b trial 56 Phenoptin 56 elagolix 56 Phase 1b 56 L MTP PE 56 romidepsin 56 placebo controlled clinical 56 Pivotal Trial 56 Phase 2b clinical 55 tanespimycin 55 TRITON TIMI 55 Phase III clinical 55 HGS ETR1 55 double blinded placebo 55 HER2 positive metastatic breast 55 Phase Ib 55 CoFactor 55 pivotal Phase 55 pivotal Phase III 55 PROMACTA 55 nab paclitaxel 55 placebo controlled randomized 54 tesmilifene 54 relapsed refractory multiple myeloma 54 RTOG 54 SPIRIT III 54 neoadjuvant 54 dose escalation 54 confirmatory Phase 3 54 subgroup analyzes 54 Phase III 54 IMC A# 54 FavId 54 randomized Phase 54 active comparator 54 Phase Ia 54 Phase IIa clinical trials 54 EORTC 54 unblinded 53 CR# vcMMAE 53 Board DSMB 53 prospective observational 53 Neuradiab 53 Phase 2b 53 dose escalation study 53 Restanza 53 SILENOR TM 53 RECIST criteria 53 CA4P 53 TELCYTA 53 Phase III randomized 53 Phase IIb clinical 53 efficacy endpoints 53 SUTENT 53 randomized controlled clinical 53 clinical endpoints 52 Phase III Trial 52 Clinical Trial Results 52 TASQ 52 TOCOSOL Paclitaxel 52 Marketing Authorization Application 52 Phase IIb 52 rNAPc2 52 ThermoDox ® 52 FOLOTYN 52 virologic response 52 liver metastases 52 cytogenetic response 52 GVAX 52 composite endpoint 52 prospective randomized controlled 52 neoadjuvant therapy 52 lymphoma CTCL 52 Biologics License Application BLA 52 Phase IIa clinical 52 refractory multiple myeloma 52 DR Cysteamine